top of page
Norwegian Cancer Precision Medicine Implementation Consortium
Latest news
Jul 7, 20213 min read
New partners join precision medicine consortium
Five new partners have joined CONNECT.
Jun 14, 20212 min read
CONNECT educational seminar
Watch the engaging presentations from the first CONNECT educational seminar for the Norwegian oncology community. CONNECT Working Group 1...
May 31, 20212 min read
CONNECT Seminar on Real-World Data
Learn more about the use of real-world data (RWD) for regulatory processes from two presentations held at a recent CONNECT meeting.
May 12, 20211 min read
CONNECT Seminar on Horizon Scanning Methods
Learn more about Horizon Scanning Methods from the presentations held at a recent CONNECT meeting.
Jan 29, 20213 min read
First pharma company joins IMPRESS-Norway
Roche is the first pharmaceutical company included in the national clinical study in cancer precision medicine called IMPRESS-Norway.
Dec 21, 20203 min read
Landmark public-private agreement for precision cancer medicine
CONNECT is a new initiative aiming to ensure that precision medicine reaches the patients.
Oct 13, 20203 min read
IMPRESS NORWAY: Large national precision medicine study in cancer
IMPRESS-Norway, a large national study on precision medicine against cancer, starts in the beginning of 2021.
bottom of page